MLYS
Mineralys Therapeutics, Inc. Common Stock
NASDAQ: MLYS · HEALTHCARE · BIOTECHNOLOGY
$25.56
-1.27% today
Updated 2026-04-29
Market cap
$2.11B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.29
Dividend yield
—
52W range
$13 – $48
Volume
1.2M
Mineralys Therapeutics, Inc. Common Stock (MLYS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $1.49M | $11.13M | $114.44M | $251.64M | $205.90M |
| Cash & equivalents | — | — | — | — | — |
| Current assets | $1.47M | $11.12M | $112.81M | $249.10M | $205.35M |
| Total liabilities | $5.08M | $34.05M | $166.71M | $10.48M | $14.65M |
| Current liabilities | $5.08M | $5.05M | $8.07M | $10.48M | $14.65M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — |
| Retained earnings | $-3.60M | $-23.01M | $-52.81M | $-124.71M | $-302.52M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |